{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00278",
      "entity_text" : "b3a2",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0079" ],
      "Organ" : [ "uberon:UBERON:0000105" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "Finally, the sampling time; obtaining blood samples form newly diagnosed patients is more accurate than do during imatinib treatment (even with the presence of imatinib resistance), as this tyrosine kinase inhibitor (TKI) found to affect the rare transcripts like e1a2 (Verma et al., 2009), while the coexpression of b3a2 and b2a2 may present at initial stage, but as the disease progress only one of them would prevail (Leglise et al., 1996).",
  "reading_complete" : "2020-08-04T11:07:01Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T11:05:35Z",
  "trigger" : "coexpression",
  "evidence" : [ "coexpression of b3a2" ],
  "pmc_id" : "6687619",
  "score" : 0
}